<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Tokai Pushes Edge With Three-Pronged Attack on Prostate Cancer</title>
	<atom:link href="http://www.xconomy.com/boston/2009/11/10/tokai-pushes-edge-with-three-pronged-attack-on-prostate-cancer/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/boston/2009/11/10/tokai-pushes-edge-with-three-pronged-attack-on-prostate-cancer/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sat, 11 Feb 2012 03:54:18 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.4</generator>
	<item>
		<title>By: John Arnold</title>
		<link>http://www.xconomy.com/boston/2009/11/10/tokai-pushes-edge-with-three-pronged-attack-on-prostate-cancer/comment-page-1/#comment-91730</link>
		<dc:creator>John Arnold</dc:creator>
		<pubDate>Thu, 12 Nov 2009 02:29:31 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=49790#comment-91730</guid>
		<description>As someone who is going on four years into what is still a hormone responsive case of advanced prostate cancer, I am very pleased that this sort of creativity is being applied to &quot;what comes next?&quot; for men like me who will face that day and question some day.  The more tools there are in the took kit, the better the chances of getting a right fit for any individual&#039;s unique situation.
Thanks, Tokai, the researchers who dreamed this stuff up and figured out the chemistry, and the men who will be participating in the clinical trials that will test it.  Your work on this is very much appreciated!</description>
		<content:encoded><![CDATA[<p>As someone who is going on four years into what is still a hormone responsive case of advanced prostate cancer, I am very pleased that this sort of creativity is being applied to “what comes next?” for men like me who will face that day and question some day.  The more tools there are in the took kit, the better the chances of getting a right fit for any individual’s unique situation.<br />
Thanks, Tokai, the researchers who dreamed this stuff up and figured out the chemistry, and the men who will be participating in the clinical trials that will test it.  Your work on this is very much appreciated!</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: I Am Biotech: Discover. Share. Discuss.</title>
		<link>http://www.xconomy.com/boston/2009/11/10/tokai-pushes-edge-with-three-pronged-attack-on-prostate-cancer/comment-page-1/#comment-91381</link>
		<dc:creator>I Am Biotech: Discover. Share. Discuss.</dc:creator>
		<pubDate>Tue, 10 Nov 2009 15:57:06 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=49790#comment-91381</guid>
		<description>[...] trials of a new drug that promises to fight cancer cells simultaneously with three modes of action. xconomy.com has more: Scientists have known for decades that prostate cancer cells thrive on testosterone and one of its [...]</description>
		<content:encoded><![CDATA[<p>[...] trials of a new drug that promises to fight cancer cells simultaneously with three modes of action. xconomy.com has more: Scientists have known for decades that prostate cancer cells thrive on testosterone and one of its [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

